Skip to main content

Advertisement

SpringerLink
Log in

Clinical-Morphological Risk Factors for the Development of Epilepsy in Patients with Glial and Metastatic Brain Tumors

  • Published:
Neuroscience and Behavioral Physiology Aims and scope Submit manuscript

Objective. To determine the incidence and identify the clinical-morphological risk factors for the development of epileptic seizures in patients with glial and metastatic brain tumors. Materials and methods. The study included 225 patients (88.6%) with glial and 29 (11.4%) with metastatic brain tumors. Results. Statistically significant differences in the incidence of epileptic seizures depending on age and histological characteristics of tumors, level of malignancy, location, involvement of the cerebral cortex, and displacement of midline structures were found. Conclusions. Epilepsy and epileptic seizures developed in 51.11% and 24.14% cases of glial and metastatic brain tumors, respectively. Risk factors for epileptic seizures were younger age (up to 57 years), histological characteristics corresponding to diffuse astrocytoma, anaplastic astrocytoma, oligodendroglioma, and oligoastrocytoma, malignancy grades I–III, lesions to the temporal lobe, and involvement of the cerebral cortex. Factors decreasing the risk of seizures were age over 57 years, histological characteristics corresponding to glioblastoma, metastatic tumors, malignancy grade IV, subcortical location of neoplasm, lesions to the occipital cortex, involvement of the conducting tracts (commissures) in the pathological process, subtentorial tumor location, absence of lesion in the temporal and frontal lobes of the brain, involvement of both hemispheres of the brain in the pathological process, lesions of two or more lobes of the brain, and displacement of midline structures.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. M. L. Bondy, M. E. Scheurer, B. Malmer, et al., “Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium (BTEC),” Cancer, 113, Suppl. 7, 1953–1968 (2008), https://doi.org/10.1002/cncr.23741.

  2. J. P. Posti, M. Bori, T. Kauko, et al., “Presenting symptoms of glioma in adults,” Acta Neurol. Scand., 131, No. 2, 88–93 (2015), https://doi.org/10.1111/ane.12285.

    Article  CAS  PubMed  Google Scholar 

  3. F. H. Gilles, E. Sobel, A. Leviton, et al., “Epidemiology of seizures in children with brain tumors. The Childhood Brain Tumor Consortium,” J. Neurooncol., 12, No. 1, 53–68 (1992), https://doi.org/10.1007/BF00172457.

    Article  CAS  PubMed  Google Scholar 

  4. J. Kennedy and S. U. Schuele, “Long-term monitoring of brain tumors: when is it necessary?” Epilepsia, 54, Suppl. 9, 50–55 (2013), https://doi.org/10.1111/epi.12444.

  5. M. Klein, N. H. Engelberts, H. M. van der Ploeg, et al., “Epilepsy in low-grade gliomas: the impact on cognitive function and quality of life,” Ann. Neurol., 54, No. 4, 514–520 (2003), https://doi.org/10.1002/ana.10712.

    Article  PubMed  Google Scholar 

  6. B. V. Martynov, V. E. Parfenov, G. E. Trufanov, et al., “Prognostic factors in patients with gliomas: symptom-syndrome analysis,” Vestn. Ross. Voenno-Med. Akad., No. 1, 7–14 (2010).

  7. C. Vecht, L. Royer-Perron, C. Houillier, and G. Huberfeld, “Seizures and anticonvulsants in brain tumours: frequency, mechanisms and anti-epileptic management,” Curr. Pharm. Des., 23, No. 42, 6464–6487 (2017), https://doi.org/10.2174/1381612823666171027130003.

    Article  CAS  PubMed  Google Scholar 

  8. X. Fan, Y. Li, X. Shan, et al., “Seizures at presentation are correlated with better survival outcomes in adult diffuse glioma: A systematic review and meta-analysis,” Seizure, 59, 16–23 (2018), https://doi.org/10.1016/j.seizure.2018.04.018.

    Article  PubMed  Google Scholar 

  9. M. Yu. Prokudin, M. M. Odinak, I. V. Litvinenko, et al., “Magnetic resonance spectroscopy in cerebral gliomas: biological markers.” Doctor. Ru, No. 1, 10–15 (2018).

  10. G. Kaloshi, D. Psimaras, K. Mokhtari, et al., “Supratentorial low-grade gliomas in older patients,” Neurology, 73, No. 24, 2093–2098 (2009), https://doi.org/10.1212/wnl.0b013e3181c6781e.

    Article  CAS  PubMed  Google Scholar 

  11. E. Olafsson and W. A. Hauser, “Prevalence of epilepsy in rural Iceland: a population-based study,” Epilepsia, 40, No. 11, 1529–1534 (1999), https://doi.org/10.1111/j.1528-1157.1999.tb02036.x.

    Article  CAS  PubMed  Google Scholar 

  12. A. B. Guekht, “Epidemiology and economic aspects of epilepsy,” Zh. Nevrol. Psikhiatr., 105, No. 8, 63–65 (2005).

    Google Scholar 

  13. M. S. van Breemen, E. B. Wilms, and C. J. Vecht, “Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management,” Lancet Neurol., 6, No. 5, 421–430 (2007), https://doi.org/10.1016/S1474-4422(07)70103-5.

    Article  PubMed  Google Scholar 

  14. P. L. Moots, R. J. Maciunas, D. R. Eisert, et al., “The course of seizure disorders in patients with malignant gliomas,” Arch. Neurol., 52, No. 7, 717–724 (1995), https://doi.org/10.1001/archneur.1995.00540310091021.

    Article  CAS  PubMed  Google Scholar 

  15. A. Rigamonti, F. Imbesi, A. Silvani, et al., “Pattern of care and outcome in elderly patients with glioblastoma: Data in 151 patients from 3 Lombardia Hospitals,” J. Neurol. Sci., 378, 3–8 (2017), https://doi.org/10.1016/j.jns.2017.04.030.

    Article  PubMed  Google Scholar 

  16. N. K. Aaronson, M. J. Taphoorn, J. J. Heimans, et al., “Compromised health-related quality of life in patients with low-grade glioma,” J. Clin. Oncol., 29, No. 33, 4430–4435 (2011), https://doi.org/10.1200/JCO.2011.35.5750.

    Article  PubMed  Google Scholar 

  17. M. Klein, M. J. Taphoorn, J. J. Heimans, et al., “Neurobehavioral status and health-related quality of life in newly diagnosed highgrade glioma patients,” J. Clin. Oncol., 19, No. 20, 4037–4047 (2001), https://doi.org/10.1200/JCO.2001.19.20.4037.

    Article  CAS  PubMed  Google Scholar 

  18. K. L. Chaichana, S. L. Parker, A. Olivi, and A. Quinones-Hinojosa, “Long-term seizure outcomes in adult patients undergoing primary resection of malignant brain astrocytomas. Clinical article,” J. Neurosurg., 111, No. 2, 282–292 (2009), https://doi.org/10.3171/2009.2.JNS081132.

    Article  PubMed  Google Scholar 

  19. M. Kerkhof and C. J. Vecht, “Seizure characteristics and prognostic factors of gliomas,” Epilepsia, 54, Supplement 9, 12–17 (2013), https://doi.org/10.1111/epi.12437.

  20. X. Su, H. L. Chen, Z. Y. Wang, et al., “Relationship between tumour location and preoperative seizure incidence in patients with gliomas: a systematic review and meta-analysis,” Epileptic Disord., 17, No. 4, 397–408 (2015), https://doi.org/10.1684/epd.2015.0788.

    Article  PubMed  Google Scholar 

  21. C. Huang, H. Li, M. Chen, et al., “Factors associated with preoperative and postoperative epileptic seizure in patients with cerebral ganglioglioma,” Pak. J. Med. Sci., 30, No. 2, 245–249 (2014), https://doi.org/10.12669/pjms.302.4362.

Download references

Author information

Authors and Affiliations

  1. Kirov Military Medical Academy, Russian Federation Ministry of Defense, St. Petersburg, Russia

    M. Yu. Prokudin, M. M. Odinak, I. V. Litvinenko, B. V. Martynov, D. V. Svistov & S. E. Bushurov

  2. Mechnikov North-West Sate Medical University, Russian Ministry of Health, St. Petersburg, Russia

    O. A. Klitsenko

Authors
  1. M. Yu. Prokudin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. M. Odinak
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. I. V. Litvinenko
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. B. V. Martynov
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. D. V. Svistov
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S. E. Bushurov
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. O. A. Klitsenko
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Yu. Prokudin.

Additional information

Translated from Zhurnal Nevrologii i Psikhiatrii imeni S. S. Korsakova, Vol. 120, No. 11, Iss. 1, pp. 22–28, November, 2020.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Prokudin, M.Y., Odinak, M.M., Litvinenko, I.V. et al. Clinical-Morphological Risk Factors for the Development of Epilepsy in Patients with Glial and Metastatic Brain Tumors. Neurosci Behav Physi 51, 867–872 (2021). https://doi.org/10.1007/s11055-021-01145-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11055-021-01145-8

Keywords

Search

Navigation